中文 | English
Return
Total: 1499 , 1/150
Show Home Prev Next End page: GO
Author:(Xiaodong WANG)

1.The correlation of serum adiponectin,C-reactive protein levels and carotid atherosclerosis plaque in patients with acute cerebral infarction

Xiaodong WANG

Chinese Journal of Postgraduates of Medicine 2013;36(25):17-20

2.Study on Compatible Stability of Cefepime Dihydrochloride Mixed with Total Parenteral Nutrient

Xiaodong WANG

China Pharmacy 2007;0(26):-

3.Clinical features of gout complicate d with increased carbohydrate antigen 724

Xiaodong WANG

Chinese Journal of Rheumatology 2017;21(4):262-264

4.Research progress of H19 gene in the field of tumor research

Xiaodong WANG

Fudan University Journal of Medical Sciences 2017;44(2):224-230

5.Biocompatibility of different coronary stents and restenosis following implantation

Xiaodong WANG

Chinese Journal of Tissue Engineering Research 2007;0(09):-

6.Relationship between heme oxygenase-1 and diabetes mellitus

Xiaodong WANG ; Xiurong RAN

Chinese Journal of Postgraduates of Medicine 2013;(13):41-44

7.Skin toxicities of epidermal growth factor receptor inhibitors

Lu WANG ; Xiaodong XIE

Journal of International Oncology 2012;39(10):784-787

8.How to standardize and optimize the clinical practice pattern to improve diagnosis and treatment of age-related macular degeneration: interpretation of the Age-Related Macular Degeneration Guidelines of Royal College of Ophthalmologists

Fenghua WANG ; Xiaodong SUN

Chinese Journal of Ocular Fundus Diseases 2012;28(5):436-440

9.Relationship among pyroptosis,inflammasome and tumor

Jingxia WANG ; Xiaodong GUO

Journal of International Oncology 2016;43(9):676-680

10.Efficacy Observation on Recombinant Human Ad-p53 Injection Combined with Cisplatin for Malignant Pleural Effusion of Non-small-cell Lung Cancer with Intracavitary Administration

Nanchang YIN ; Xiaodong WANG

China Pharmacy 2001;0(12):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1499 , 1/150 Show Home Prev Next End page: GO